Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease

References

• Huerta M, Avila R, Jiménez HI et al. Parasite contamination of soil in households of a Mexican rural community endemic for neurocysticercosis. Trans. R. Soc. Trop. Med. Hyg.102, 374–379 (2008).
   PubMed Web of Science ®Google Scholar
• Prasad KN, Prasad A, Verma A, Singh AK. Human cysticercosis and Indian scenario: a review. J. Biosci.33, 571–582 (2008).
   PubMed Web of Science ®Google Scholar
• Praet N, Speybroeck N, Manzanedo R et al. The disease burden of Taenia solium cysticercosis in Cameroon. PLoS Negl. Trop. Dis.3, e406 (2009).
   PubMed Web of Science ®Google Scholar
• Fleury A, Moreno García J, Valdez Aguerrebere P et al. Neurocysticercosis, a persisting health problem in Mexico. PLoS Negl. Trop. Dis.4(8), e805 (2010).
   PubMed Web of Science ®Google Scholar
• Esquivel A, Diaz-Otero F, Gimenez-Roldan S. Growing frequency of neurocysticercosis in Madrid (Spain). Neurologia20, 116–120 (2005).
   PubMed Web of Science ®Google Scholar
• Kraft R. Cysticercosis: an emerging parasitic disease. Am. Fam. Physician76, 91–96 (2007).
   PubMed Web of Science ®Google Scholar
• Nicoletti A, Bartoloni A, Sofia V et al. Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia46, 1127–1132 (2005).
   PubMed Web of Science ®Google Scholar
• Fleury A, Morales J, Bobes RJ et al. An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans. R. Soc. Trop. Med. Hyg.100, 551–558 (2006).
   PubMed Web of Science ®Google Scholar
• Fleury A, Escobar A, Fragoso G et al. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans. R. Soc. Trop. Med. Hyg.104, 243–250 (2010).
   PubMed Web of Science ®Google Scholar
• Takayanagui OM, Odashima NS. Clinical aspects of neurocysticercosis. Parasitol. Int.55(Suppl.), S111–S115 (2006).
   PubMedGoogle Scholar
• Das K, Mondal GP, Banerjee M, Mukherjee BB, Singh OP. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study. J. Clin. Neurosci.14, 1172–1177 (2007).
   PubMed Web of Science ®Google Scholar
• Thussu A, Chattopadhyay A, Sawhney IM, Khandelwal N. Albendazole therapy for single small enhancing CSF lesions (SSECSFL) in the brain in epilepsy. J. Neurol. Neurosurg. Psychiatry79, 272–275 (2008).
   PubMed Web of Science ®Google Scholar
• Nash TE, Pretell EJ, Lescano AG et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case–control study. Lancet Neurol.7, 1099–1105 (2008).
   PubMed Web of Science ®Google Scholar
• Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann. Intern. Med.145, 43–51 (2006).
   PubMed Web of Science ®Google Scholar
• Fleury A, Dessein A, Dumas M et al. Symptomatic neurocysticercosis: host and exposure factors relating with disease heterogeneity. J. Neurol.251, 830–837 (2004).
   PubMed Web of Science ®Google Scholar
• Figueroa JJ, Davis LE, Magalhaes A. Extraparenchymal neurocysticercosis in Albuquerque, New Mexico. J. Neuroimaging. DOI: 10.1111/j.1552-6569.2009.00452.x (2009) (Epub ahead of print).
   Google Scholar
• Shandera WX, White AC Jr, Chen JC, Diaz P, Armstrong R. Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore)73, 37–52 (1994).
   PubMed Web of Science ®Google Scholar
• Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology63, 1559–1564 (2004).
   PubMed Web of Science ®Google Scholar
• Mendes EC, da Silva SS, Fonseca EA, de Souza HR, de Carvalho RW. Human neurocysticercosis in Baixada Fluminense, Rio de Janeiro State, Brazil. Arq. Neuropsiquiatr.63, 1058–1062 (2005).
   PubMed Web of Science ®Google Scholar
• Talukdar B, Saxena A, Popli VK, Choudhury V. Neurocysticercosis in children: clinical characteristics and outcome. Ann. Trop. Paediatr.22, 333–339 (2002).
   PubMed Web of Science ®Google Scholar
• Sáenz B, Ruiz-Garcia M, Jiménez E et al. Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults. Pediatr. Infect. Dis. J.25, 801–803 (2006).
   PubMed Web of Science ®Google Scholar
• Singh G. Neurocysticercosis in South-Central America and the Indian subcontinent. A comparative evaluation. Arq. Neuropsiquiatr.55, 349–56 (1997).
   PubMed Web of Science ®Google Scholar
• Bobes RJ, Fragoso G, Reyes-Montes MR et al. Genetic diversity of Taenia solium cysticerci from naturally infected pigs of central Mexico. Vet. Parasitol.168, 130–135 (2010).
   PubMed Web of Science ®Google Scholar
• Maravilla P, Gonzalez-Guzman R, Zuñiga G et al. Genetic polymorphism in Taenia solium cysticerci recovered from experimental infections in pigs. Infect. Genet. Evol.8, 213–216 (2008).
   PubMed Web of Science ®Google Scholar
• Biagi F, Briceño CE, Martinez B. Diferencias entre Cysticercus cellulosae y C. racemosus. Revista de Biología Tropical (Mexico)9(2), 141–152 (1961).
   Google Scholar
• Rabiela-Cervantes MT, Rivas-Hernández A, Castillo-Medina S, González-Angulo A. Morphological evidence indicating that C. cellulosae and C. racemosus are larval stages of Taenia solium. Arch. Invest. Med. (Mex)16(1), 81–92 (1985).
   PubMedGoogle Scholar
• Hinojosa-Juarez AC, Sandoval-Balanzario M, McManus DP, Monroy-Ostria A. Genetic similarity between cysticerci of Taenia solium isolated from human brain and from pigs. Infect. Genet. Evol.8(5), 653–656 (2008).
   PubMed Web of Science ®Google Scholar
• Escobar A. The pathology of neurocysticercosis. In: Cysticercosis of the Nervous System. Palacios E, Rodríguez-Carbajal J, Taveras JM (Eds). Charles C Thomas Publisher, IL, USA, 27–54 (1983).
   Google Scholar
• Hortobágyi T, Alhakim A, Biedrzycki O, Djurovic V, Rawal J, Al-Sarraj S. Cysticercosis of the fourth ventricle causing sudden death: a case report and review of the literature. Pathol. Oncol. Res.15, 143–146 (2009).
   PubMed Web of Science ®Google Scholar
• DeGiorgio CM, Houston I, Oviedo S, Sorvillo F. Deaths associated with cysticercosis. Report of three cases and review of the literature. Neurosurg. Focus12, e2 (2002).
   Google Scholar
• Santo AH. Cysticercosis-related mortality in the State of São Paulo, Brazil, 1985–2004: a study using multiple causes of death. Cad. Saude. Publ.23, 2917–2927 (2007).
   PubMed Web of Science ®Google Scholar
• Oka Y, Fukui K, Shoda D et al. Cerebral cysticercosis manifesting as hydrocephalus, case report. Neurol. Med. Chir. (Tokyo)36, 654–658 (1996).
   PubMedGoogle Scholar
• Estañol B, Kleriga E, Loyo M et al. Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy. Neurosurgery13, 119–123 (1983).
   PubMed Web of Science ®Google Scholar
• Chavarria A, Fleury A, Garcia E, Marquez C, Fragoso G, Sciutto E. Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clin. Immunol.116, 271–278 (2005).
   PubMed Web of Science ®Google Scholar
• Fleury A, Escobar E, Chavarria A, Carrillo-Mezo R, Sciutto E. Cisticercosis en el ser humano. In: Cisticercosis: Guía para profesionales de la Salud. Larralde C, de Aluja A (Eds). Biblioteca de la salud, Fondo de Cultura Económica, México, 41–86 (2006).
   Google Scholar
• Aditya GS, Mahadevan A, Santosh V, Chickabasaviah YT, Ashwathnarayanarao CB, Krishna SS. Cysticercal chronic basal arachnoiditis with infarcts, mimicking tuberculous pathology in endemic areas. Neuropathology24, 320–325 (2004).
   PubMed Web of Science ®Google Scholar
• Rabiela MT, Rivas A, Castillo S, Cancino F. Anatomopathologial aspects of human brain cysticercosis. In: Cysticercosis. Present State of Knowledge and Perspectives. Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltran F (Eds). Academic Press, NY, USA, 179–200 (1982).
   Google Scholar
• McAllister JP 2nd. Neuronal damage in hydrocephalus. J. Neurosurg.104(5 Suppl.), 297–298 (2006).
   PubMed Web of Science ®Google Scholar
• Joubert J. Cysticercal meningitis, a pernicious form of neurocysticercosis, which responds poorly to praziquantel. S. Afr. Med. J.77, 528–530 (1990).
   PubMed Web of Science ®Google Scholar
• Oliveira JP, Morais SL, Araújo D et al. Mood disorder due to a general medical condition with manic features. Case Report Med.2009, 871365 (2009).
   PubMedGoogle Scholar
• Agapejev S, Pouza AF, Bazan R, Faleiros AT. Clinical and evolutive aspects of hydrocephalus in neurocysticercosis. Arq. Neuropsiquiatr.65, 674–680 (2007).
   PubMed Web of Science ®Google Scholar
• Forlenza OV, Filho AH, Nobrega JP et al. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J. Neurol. Neurosurg. Psychiatry62, 612–616 (1997).
   PubMed Web of Science ®Google Scholar
• Xie S, Wei G, Zhao L. Intellectual status of patents cerebral cysticercosis. Zhonghua Yi Xue Za Zhi76, 440–442 (1996).
   PubMedGoogle Scholar
• Del Bigio MR, Wilson MJ, Enno T. Chronic hydrocephalus in rats and humans: white matter loss and behavior changes. Ann. Neurol.53, 337–346 (2003).
   PubMed Web of Science ®Google Scholar
• Kondziella D, Sonnewald U, Tullberg M, Wikkelso C. Brain metabolism in adult chronic hydrocephalus. J. Neurochem.106, 1515–1524 (2008).
   PubMed Web of Science ®Google Scholar
• Egawa T, Mishima K, Egashira N et al. Impairment of spatial memory in kaolin-induced hydrocephalic rats is associated with changes in the hippocampal cholinergic and noradrenergic contents. Behav. Brain. Res.129, 31–39 (2002).
   PubMed Web of Science ®Google Scholar
• Ramirez-Bermudez J, Higuera J, Sosa AL, Lopez-Meza E, Lopez-Gomez M, Corona T. Is dementia reversible in patients with neurocysticercosis? J. Neurol. Neurosurg. Psychiatry76, 1164–1166 (2005).
   PubMed Web of Science ®Google Scholar
• Chang GY, Keane JR. Visual loss in cysticercosis: analysis of 23 patients. Neurology57, 545–548 (2001).
   PubMed Web of Science ®Google Scholar
• Besada E, Barr R, Natu A. Bilateral disk edema with unilateral macular serous fluid secondary to neurocysticercosis. Optometry76, 239–249 (2005).
   PubMedGoogle Scholar
• Keane JR. The pretectal syndrome: 206 patients. Neurology40, 684–690 (1990).
   PubMed Web of Science ®Google Scholar
• Sá DS, Teive HA, Troiano AR, Werneck LC. Parkinsonism associated with neurocysticercosis. Parkinsonism Relat. Disord.11, 69–72 (2005).
   PubMed Web of Science ®Google Scholar
• Keane JR. Tremor as the result of shunt obstruction: four patients with cysticercosis and secondary parkinsonism: report of four cases. Neurosurgery37, 520–522 (1995).
   PubMed Web of Science ®Google Scholar
• Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov. Disord.9, 508–520 (1994).
   PubMed Web of Science ®Google Scholar
• Racette BA, Esper GJ, Antenor J et al. Pathophysiology of parkinsonism due to hydrocephalus. J. Neurol. Neurosurg. Psychiatry75, 1617–1619 (2004).
   PubMed Web of Science ®Google Scholar
• Góngora-Rivera F, Soto-Hernández JL, Guevara P, Sotelo-Morales J. In neurocysticercosis, CSF cytokines correlate with cerebral blood flow velocities. Neurology71, 1119–1122 (2008).
   PubMed Web of Science ®Google Scholar
• Alarcón F, Hidalgo F, Moncayo J, Viñán I, Dueñas G. Cerebral cysticercosis and stroke. Stroke23, 224–228 (1992).
   PubMed Web of Science ®Google Scholar
• Del Brutto OH. Cysticercosis and cerebrovascular disease: a review. J. Neurol. Neurosurg. Psychiatry55, 252–254 (1992).
   PubMed Web of Science ®Google Scholar
• Barinagarrementeria F, Cantú C. Frequency of cerebral arthritis in subarachnoid cysticercosis: an angiographic study. Stroke29, 123–125 (1998).
   PubMed Web of Science ®Google Scholar
• Cantú C, Barinagarrementeria F. Cerebrovascular complications of neurocysticercosis. Clinical and neuroimaging spectrum. Arch. Neurol.53, 233–239 (1996).
   PubMedGoogle Scholar
• Castro-Lima H, Raicher I, Lee HW, Marchiori PE. Neurocysticercosis presenting with stroke. Arq. Neuropsiquiatr.68, 146 (2010).
   PubMed Web of Science ®Google Scholar
• Barinagarrementeria F, Del Brutto OH. Neurocysticercosis and pure motor hemiparesis. Stroke19, 1156–1158 (1988).
   PubMed Web of Science ®Google Scholar
• Barinagarrementeria F, del Brutto OH. Lacunar syndrome due to neurocysticercosis. Arch. Neurol.46, 415–417 (1989).
   PubMedGoogle Scholar
• Levy AS, Lillehei KO, Rubinstein D, Stears JC. Subarachnoid neurocysticercosis with occlusion of major intracranial vessels: case report. Neurosurgery36, 183–188 (1995).
   PubMed Web of Science ®Google Scholar
• Monteiro L, Almeida-Pinto J, Leite I, Xavier J, Correia M. Cerebral cysticercus arteritis: five angiographic cases. Cerebrovasc. Dis.4, 125–133 (1994).
   Web of Science ®Google Scholar
• Rodriguez-Carbajal J, Del Brutto OH, Penagos P, Huebe J, Escobar A. Occlusion of the middle cerebral artery due to cysticercotic angiitis. Stroke20, 1095–1098 (1989).
   PubMed Web of Science ®Google Scholar
• Sawhney IM, Singh G, Lekhra OP, Mathuriya SN, Parihar PS, Prabhakar S. Uncommon presentations of neurocysticercosis. J. Neurol. Sci.154, 94–100 (1998).
   PubMed Web of Science ®Google Scholar
• Garg RK, Karak B. Neurocysticercosis presenting as midbrain syndrome. J. Assoc. Physicians. India48, 533–535 (2000).
   PubMedGoogle Scholar
• Arauz A, López M, Cantú C, Barinagarrementeria F. Nonaneurysmal subarachnoid hemorrhage. Study of long-term follow-up. Neurologia22, 502–506 (2007).
   PubMed Web of Science ®Google Scholar
• Kim IY, Kim TS, Lee JH, Lee MC, Lee JK, Jung S. Inflammatory aneurysm due to neurocysticercosis. J. Clin. Neurosci.12, 585–588 (2005).
   PubMed Web of Science ®Google Scholar
• Soto-Hernandez JL, Gomez-Llata S, Rojas-Echeverri LA, Texeira F, Romero V. Subarachnoid hemorrhage secondary to a ruptured inflammatory aneurysm: a possible manifestation of neurocysticercosis: case report. Neurosurgery38, 197–199 (1996).
   PubMed Web of Science ®Google Scholar
• Tellez-Zenteno JF, Negrete-Pulido O, Cantú C, Márquez C, Vega-Boada F, García-Ramos G. Hemorrhagic stroke associated to neurocysticercosis. Neurologia18, 272–275 (2003).
   PubMed Web of Science ®Google Scholar
• Ranjith MP, Divya R, Sahni A. Isolated third cranial nerve palsy: a rare presentation of neurocysticercosis. Ir. J. Med. Sci. DOI: 10.1007/s11845-009-0308-6 (2009) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Kim JS, Jeong SM, Moon SY, Park SH. Third cranial nerve palsy from midbrain neurocysticercosis: repeated exacerbation on tapering corticosteroids. J. Neuroophthalmol.24, 217–220 (2004).
   PubMed Web of Science ®Google Scholar
• Colli BO, Martelli N, Assirati Jr JÁ et al. Cysticercosis of the central nervous system. I. Surgical treatment of cerebral cysticercosis: a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School. Arq. Neuropsiquiat.52, 166–186 (1994).
   PubMedGoogle Scholar
• Chang JH, Chang JW, Park YG, Kim TS. Cysticercosis of cerebellopontine cistern: differential diagnosis using MRI. Acta Neurochir. (Wien)146, 325–328 (2004).
   PubMed Web of Science ®Google Scholar
• Revuelta R, Soto-Hernández JL, Vales LO, González RH. Cerebellopontine angle cysticercus and concurrent vascular compression in a case of trigeminal neuralgia. Clin. Neurol. Neurosurg.106, 19–22 (2003).
   PubMed Web of Science ®Google Scholar
• del Brutto OH. Cysticercosis of the cerebellopontine angle: treatment with single-dose praziquantel. Rev. Neurol.3, 835–837 (2000).
   Google Scholar
• Aguiar PH, Miura FK, Napoli PR et al. Unusual cause for bilateral trigeminal neuralgia: unilateral racemous cysticercus of cerebellopontine angle. Case report. Arq. Neuropsiquiatr.58, 1138–1141 (2000).
   PubMed Web of Science ®Google Scholar
• Lucato LT, Guedes MS, Sato JR, Bacheschi LA, Machado LR, Leite CC. The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: impact on characterization of the scolex and lesion burden. Am. J. Neuroradiol.28, 1501–1504 (2007).
   PubMed Web of Science ®Google Scholar
• Do Amaral LL, Ferreira RM, da Rocha AJ, Ferreira NP. Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top. Magn. Reson. Imaging.16, 127–144 (2005).
   PubMedGoogle Scholar
• Braga F, Rocha AJ, Gomes HR, Filho GH, Silva CJ, Fonseca RB. Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% Supplemental O2 in the evaluation of neurocysticercosis. AJNR25, 295–297 (2004).
   PubMed Web of Science ®Google Scholar
• Fleury A, Hernández M, Avila M et al. Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocisticercosis. J. Neurol. Neurosurg. Psychiatry78, 970–974 (2007).
   PubMed Web of Science ®Google Scholar
• Nguekam Zoli AP, Ongolo-Zogo P, Dorny P, Brandt J, Geerts S. Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA. Parasite10(1), 65–68 (2003).
   PubMed Web of Science ®Google Scholar
• Bobes RJ, Hernandez M, Marquez C et al. Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up. Trop. Med. Int. Health11, 943–950 (2006).
   PubMed Web of Science ®Google Scholar
• Ostrosky-Zeichner L, Garcia-Mendoza E, Rios C, Sotelo J. Humoral and cellular immune response within the subarachnoid space of patients with neurocysticercosis. Arch. Med. Res.27, 513–517 (1996).
   PubMed Web of Science ®Google Scholar
• Rodrigues V Jr, de-Mello FA, Magalhaes EP, Ribeiro SB, Marquez JO. Interleukin-5 and interleukin-10 are major cytokines in cerebrospinal fluid from patients with active neurocysticercosis. Braz. J. Med. Biol. Res.33, 1059–1063 (2000).
   PubMed Web of Science ®Google Scholar
• Aguilar-Rebolledo F, Cedillo-Rivera R, Llaguno-Violante P, Torres-López J, Muñoz-Hernández O, Enciso-Moreno JA. Interleukin levels in cerebrospinal fluid from children with neurocysticercosis. Am. J. Trop. Med. Hyg.64, 35–40 (2001).
   PubMedGoogle Scholar
• Chavarría A, Fleury A, Bobes RJ, Morales J, Fragoso G, Sciutto E. A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis. Microbes Infect.8, 1082–1089 (2006).
   PubMed Web of Science ®Google Scholar
• Sciutto E, Chavarria A, Fragoso G, Fleury A, Larralde C. The immune response in Taenia solium cysticercosis: protection and injury. Parasite Immunol.29, 621–636 (2007).
   PubMed Web of Science ®Google Scholar
• Lopez JA, Garcia E, Cortes IM, Sotelo J, Tato P, Molinari JL. Neurocysticercosis: relationship between the developmental stage of metacestode present and the titre of specific IgG in the cerebrospinal fluid. Ann. Trop. Med. Parasitol.98, 569–579 (2004).
   PubMed Web of Science ®Google Scholar
• Molinari JL, Garcia-Mendoza E, de la Garza Y, Ramirez JA, Sotelo J, Tato P. Discrimination between active and inactive neurocysticercosis by metacestode excretory/secretory antigens of Taenia solium in an enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg.66, 777–7781 (2002).
   PubMed Web of Science ®Google Scholar
• Jimenez-Vazquez OH, Nagore N. Cisternal neurocysticercosis. Br. J. Neurosurg.22, 774–775 (2008).
   PubMed Web of Science ®Google Scholar
• Rajshekhar V. Surgical management of neurocysticercosis. Int. J. Surg.8, 100–104 (2010).
   PubMed Web of Science ®Google Scholar
• Gravori T, Steineke T, Bergsneider M. Endoscopic removal of cisternal neurocysticercal cysts. Technical note. Neurosurg. Focus12, e7 (2002).
   Google Scholar
• Proaño JV, Torres-Corzo J, Rodríguez-Della Vecchia R, Guizar-Sahagun G, Rangel-Castilla L. Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv. Syst.25, 1467–1475 (2009).
   PubMed Web of Science ®Google Scholar
• Cárdenas G, Carrillo-Meza R, Jung H, Sciutto E, Soto Hernandez JL, Fleury A. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series. BMC Neurol.10, 16 (2010).
   PubMed Web of Science ®Google Scholar
• Del Brutto OH, Sotelo J. Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report. J. Neurosurg.72, 816–817 (1990).
   PubMed Web of Science ®Google Scholar
• Bandres JC, White AC Jr, Samo T, Murphy EC, Harris RL. Extraparenchymal neurocysticercosis: report of five cases and review of management. Clin. Infect. Dis.15, 799–811 (1992).
   PubMed Web of Science ®Google Scholar
• Del Brutto OH. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. J. Neurol. Neurosurg. Psychiatry62, 659–661 (1997).
   PubMed Web of Science ®Google Scholar
• Proano JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N. Engl. J. Med.345, 879–885 (2001).
   PubMed Web of Science ®Google Scholar
• Gongora-Rivera F, Soto-Hernandez JL, Gonzalez Esquivel D et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology66, 436–438 (2006).
   PubMed Web of Science ®Google Scholar
• Marquez-Caraveo C, Gongora-Rivera F, Santos Zambrano J, Hernandez R, Soto-Hernandez JL. Pre-treatment with corticosteroids and a single cycle of high dose albendazole for subarachnoidal cysticercosis. J. Neurol. Neurosurg. Psychiatry.75, 938–939 (2004).
   PubMed Web of Science ®Google Scholar
• Jung H, Cárdenas G, Sciutto E, Fleury A. Medical treatment for neurocysticercosis: drugs, indications and perspectives. Curr. Top. Med. Chem.8, 424–433 (2008).
   PubMed Web of Science ®Google Scholar
• Suastegui-Roman RA, Soto-Hernandez JL, Sotelo J. Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J. Neurosurg.84, 629–633 (1996).
   PubMed Web of Science ®Google Scholar
• Mitre E, Talaat KR, Sperling MR, Nash TE. Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis. Clin. Infect. Dis.44, 549–553 (2007).
   PubMed Web of Science ®Google Scholar
• Sotelo J, Flisser A. Neurocysticercosis Practical Treatment Guidelines. CNS Drug7, 17–25 (1997).
   Web of Science ®Google Scholar
• Sotelo J, Marin C. Hydrocephalus secondary to cysticercotic arachnoiditis. J. Neurosurg.66, 686–689 (1987).
   PubMed Web of Science ®Google Scholar
• Kelley R, Duong DH, Locke GE. Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery50, 757–761 (2002).
   PubMed Web of Science ®Google Scholar
• Keane JR. Tremor as the result of shunt obstruction: four patients with cysticercosis and secondary parkinsonism: report of four cases. Neurosurgery37, 520–522 (1995).
   PubMed Web of Science ®Google Scholar
• Stanbury RM, Graham EM. Systemic corticosteroid therapy – side effects and their management. Br. J. Ophthalmol.82, 704–708 (1998).
   PubMed Web of Science ®Google Scholar